NDC 68180-0513 - Lisinopril and hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-0513
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lisinopril and hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 86e7a336-c416-6fab-e053-2a91aa0a274c | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 7cd7c59d-ce52-1f5b-e053-2a91aa0a8f86 | 2024-06-12 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 7e7cb50d-c984-5c01-e053-2a91aa0a68a5 | 2024-06-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 6c57bf12-9ad5-3a25-e053-2a91aa0aaf26 | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 72c97b7f-d945-5106-e053-2a91aa0a9b3b | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | 973973a3-9fec-4afc-910f-187f099dfe2d | 2024-06-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 1a04bf47-07fb-ed32-e063-6294a90a07cc | 2024-06-03 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 6a11a458-dc69-40ba-a58a-649733e0e8ab | 2024-05-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 447c11b6-72fe-418e-a2db-5d90b5347796 | 2024-05-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 2b66693d-0514-4f41-b405-bd3dd7618e81 | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | 02eb8f54-789e-4148-912b-601d23a7df4a | 2024-05-23 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 4c74bc01-1065-79f0-f9c4-044ead38a55d | 2024-05-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| Amlodipine, Valsartan and Hydrochlorothiazide | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 6fba5243-ee00-4825-a04a-321cb6b49c56 | 2024-05-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2024-05-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1884db5f-72b5-6b0c-e063-6394a90a0e49 | 2024-05-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb08103-04ee-47a6-a9ad-290e169feb51 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | c8740506-c679-4c41-a96a-8ddbcddd72c6 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Exelan Pharmaceuticals, Inc | 4aad4d30-3e18-489c-80ad-ccf7532bb933 | 2024-05-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | abf2fe45-8b69-4d3c-981e-289c0aa3e98b | 2024-05-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c6ed6f74-0eca-4f99-8c7e-dd3f56167f01 | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.